Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
NCT ID: NCT01197079
Last Updated: 2025-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2010-08-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. to determine the degree of understanding and perceived risks for human papillomavirus (HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and identify potential barriers to HPV vaccine access and utilization in a population of young men who have sex with men (MSM) (under 26 years of age)and in parents of boys aged 9 to 18 years
2. to determine HPV vaccine acceptance and predictors of acceptance in a population of young MSM and in patients of boys ages 9 to 18 years
3. to develop strategies to overcome potential barriers to vaccination and improve vaccine access and utilization via development of targeted educational initiatives.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
NCT04945655
Video to Promote HPV Vaccination
NCT02196454
The STOP-HPV Trial 1: Communication Intervention
NCT03599557
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
NCT01300689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parents - Private Pediatric Offices
Parents of Boys aged 9 to 18 years from Private Pediatric Offices
Survey
Self administered anonymous survey
Parents - Public Health Clinics
Parents of Boys aged 9 to 18 years from Public Health Clinics
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Self administered anonymous survey
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parent group - parent of boy(s) ages 9 to 18 years
Exclusion Criteria
* Parent group - previous receipt of HPV vaccine by male child
9 Years
26 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tina Q. Tan
Professor of Pediatrics, Attending Physician - Infectious Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Private practice
Chicago, Illinois, United States
Children's Memorial Hospital Uptown Clinic
Chicago, Illinois, United States
Pediatric Private Practice
Chicago, Illinois, United States
Erie Family Health Clinic
Chicago, Illinois, United States
Howard Brown Health Center
Chicago, Illinois, United States
Private pediatric practice
Evanston, Illinois, United States
Pediatric Private practice
Evanston, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Merck IISP 37875
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.